GapMind for catabolism of small carbon sources

 

Alignments for a candidate for PPDCalpha in Frankia alni ACN14A

Align phenylpyruvate decarboxylase (EC 4.1.1.43) (characterized)
to candidate WP_011604188.1 FRAAL_RS13280 thiamine pyrophosphate-dependent dehydrogenase E1 component subunit alpha

Query= BRENDA::A0A222AKA3
         (368 letters)



>NCBI__GCF_000058485.1:WP_011604188.1
          Length = 342

 Score =  155 bits (391), Expect = 2e-42
 Identities = 108/311 (34%), Positives = 158/311 (50%), Gaps = 19/311 (6%)

Query: 23  VTAAPAAAAPAAAGVPPDR--QLLMYRAMVVGRAFNRQATAFSRQGRLA-VYPSSRGQEA 79
           ++A P +AA      PPD   QL ++R       F+ +  +    G +  +Y S RGQE 
Sbjct: 3   ISAPPDSAAAVDFSAPPDLDVQLGLFRTATRIARFDEKYRSLMTSGAIGGMYYSPRGQEF 62

Query: 80  CQVGSALAVRPTDWLFPTYRESVALLTRGIDPVQVLTLFRGDQH--CGYDPVTEH-TAPQ 136
                A  +R  D++  TYR     + +G+   ++   + G     CG      H TAP+
Sbjct: 63  AAASVAAHLRRDDYVVTTYRGLHDQIAKGVPLRELWAEYLGKAAGTCGGKGGPMHVTAPE 122

Query: 137 CTPLATQCLH------AAGLADAARMAGDPIVALAYIGDGATSEGDFHEALNYAAVRRAP 190
              + T  +       A GLA +A++ G   V +   GDGA++ G FHE+LN A++ R P
Sbjct: 123 YGLMVTTGVVGSGLPIANGLALSAQLRGTDQVTVVNFGDGASNIGAFHESLNLASIWRLP 182

Query: 191 VVFLVQNNQYAISVPLAKQTAARTLADKAAGYGMPGVRIDGNDVLQVYRAVHDAAERARA 250
           V+F+ QNN+YA   PL + T+   +A +AA Y +PGV +DGND +++Y A   A ERAR 
Sbjct: 183 VIFVCQNNRYAEYTPLREGTSVDRIAQRAAAYSLPGVTVDGNDPIELYNAAGAAIERART 242

Query: 251 GHGPTLIEAVTYRIDAHTNADDDTRYRPAGEADVWAAQDPVDRLERDLLA------AGVL 304
           G GPTL+EA+T+R   H   D    Y P  E     A DP+ R    L A         +
Sbjct: 243 GGGPTLLEAMTFRFCGHIMGDQQV-YMPPEELRAAIAADPLVRFRAQLAADVGEDELAAV 301

Query: 305 DRAAADGIAAA 315
           +RAAAD +A A
Sbjct: 302 ERAAADEVADA 312


Lambda     K      H
   0.319    0.132    0.395 

Gapped
Lambda     K      H
   0.267   0.0410    0.140 


Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Sequences: 1
Number of Hits to DB: 295
Number of extensions: 16
Number of successful extensions: 3
Number of sequences better than 1.0e-02: 1
Number of HSP's gapped: 1
Number of HSP's successfully gapped: 1
Length of query: 368
Length of database: 342
Length adjustment: 29
Effective length of query: 339
Effective length of database: 313
Effective search space:   106107
Effective search space used:   106107
Neighboring words threshold: 11
Window for multiple hits: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.8 bits)
S2: 49 (23.5 bits)

This GapMind analysis is from Sep 24 2021. The underlying query database was built on Sep 17 2021.

Links

Downloads

Related tools

About GapMind

Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.

A candidate for a step is "high confidence" if either:

where "other" refers to the best ublast hit to a sequence that is not annotated as performing this step (and is not "ignored").

Otherwise, a candidate is "medium confidence" if either:

Other blast hits with at least 50% coverage are "low confidence."

Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:

GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).

For more information, see:

If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know

by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory